glp 1 antidiabetic GLP-1 and GIP in Type Diabetes Therapy: A Time for Reappraisal? GLP-1 mimetics and cognition -
Description
Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021

Individual results may vary
Save on your order from IsraelPharm

Indulge without the guilt
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
PF-07976016 - oral GIPR antagonist Phase 2

